Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05630131
What this trial is testing

CtDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

Who this might be right for
Bladder CancerMuscle-Invasive Bladder Carcinoma
UNC Lineberger Comprehensive Cancer Center 1
Not applicableNot Yet RecruitingNCT07525349
What this trial is testing

Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder CarcinomaUrothelial Carcinoma (UC)Bladder Cancer+2 more
Assiut University 100
Not applicableLooking for participantsNCT04900558
What this trial is testing

Robotic Radical Cystectomy Outcomes

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaOncology+2 more
University of Florence 500
Testing effectiveness (Phase 2)UnknownNCT04876313
What this trial is testing

An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)

Who this might be right for
Muscle-Invasive Bladder Carcinoma
IRCCS San Raffaele 29
Testing effectiveness (Phase 2)Ended earlyNCT05581589
What this trial is testing

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
University of Washington 4
Post-approval studies (Phase 4)UnknownNCT06215976
What this trial is testing

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Cairo University 78
Large-scale testing (Phase 3)UnknownNCT03664869
What this trial is testing

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Turku University Hospital 300
Large-scale testing (Phase 3)Looking for participantsNCT07000084
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Who this might be right for
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8
Alliance for Clinical Trials in Oncology 330
Testing effectiveness (Phase 2)Looking for participantsNCT06257017
What this trial is testing

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Yung NA 20
Testing effectiveness (Phase 2)Looking for participantsNCT06417190
What this trial is testing

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Who this might be right for
Muscle-Invasive Bladder CarcinomaTumor
Leslie Ballas 20
Not applicableStudy completedNCT05028660
What this trial is testing

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Elypta 43
Testing effectiveness (Phase 2)UnknownNCT04543110
What this trial is testing

Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC

Who this might be right for
Bladder Cancer
Ottawa Hospital Research Institute 16
Testing effectiveness (Phase 2)Looking for participantsNCT06341400
What this trial is testing

RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Who this might be right for
Bladder CancerMuscle-Invasive Bladder Carcinoma
Zhujiang Hospital 55
Post-approval studies (Phase 4)Looking for participantsNCT07474519
What this trial is testing

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Carcinoma
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT04724928
What this trial is testing

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
University Hospital, Ghent 156
Large-scale testing (Phase 3)Looking for participantsNCT06493552
What this trial is testing

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Who this might be right for
Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT05406713
What this trial is testing

Pembrolizumab in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder CarcinomaLocalized CancerUrothelial Carcinoma
Matthew Galsky 46
Testing effectiveness (Phase 2)Study completedNCT04383743
What this trial is testing

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Stage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma
University of Washington 17
Testing effectiveness (Phase 2)Looking for participantsNCT06733363
What this trial is testing

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder CarcinomaRecurrent Bladder CarcinomaRecurrent Non-Muscle Invasive Bladder Carcinoma+2 more
Roswell Park Cancer Institute 344
Testing effectiveness (Phase 2)UnknownNCT05297552
What this trial is testing

RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Carcinoma
RemeGen Co., Ltd. 40
Next Page